These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 790556)

  • 21. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
    Kozin F; Fowler M
    Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
    Cruz M; Mejia G; Lavalle C; Cortes JJ; Reyes PA
    Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.
    Kurata N; Tan EM
    Arthritis Rheum; 1976; 19(3):574-80. PubMed ID: 1084750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The measurement of antibodies to extractable nuclear antigen.
    Dorsch CA; White GM; Berzofsky RN
    Am J Clin Pathol; 1979 Mar; 71(3):333-7. PubMed ID: 107791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mixed connective tissue disease (Sharp's syndrome)].
    Müller W; Rosenthal M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():744-50. PubMed ID: 306173
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
    Sharp GC; Irvin WS; LaRoque RL; Velez C; Daly V; Kaiser AD; Holman HR
    J Clin Invest; 1971 Feb; 50(2):350-9. PubMed ID: 4992992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE.
    Warlow RS
    Scand J Rheumatol; 1986; 15(1):57-67. PubMed ID: 2421399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of ribonucleoprotein antibody.
    Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
    Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed connective tissue disease syndrome.
    Gilliam JN; Prystowsky SD
    Arch Dermatol; 1977 May; 113(5):583-7. PubMed ID: 67824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
    Mulli JC; Cruchaud A
    Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
    McMillan SA; Fay AC; Taggart AJ; McCrea JD; Roberts SD; Boyd MW; Nelson JK; Haire M
    Ulster Med J; 1986 Oct; 55(2):112-7. PubMed ID: 3492803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed connective tissue disease.
    Minkin W; Rabhan N
    Arch Dermatol; 1976 Nov; 112(11):1535-8. PubMed ID: 1086651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection.
    Boonpucknavig S; Ekapanyakul G
    Clin Exp Immunol; 1984 Oct; 58(1):77-82. PubMed ID: 6383670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
    Miyachi K; Tan EM
    Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.